Luma Vision Ltd.
Clinical trials sponsored by Luma Vision Ltd., explained in plain language.
-
New 3D imaging tool could make heart ablation more precise
Disease control Not yet recruitingThis study will test a new navigation and imaging system (VERAFEYE) in 100 adults with paroxysmal atrial fibrillation who are scheduled for catheter ablation. The goal is to see if the system helps doctors successfully create a 3D model of the heart and complete the ablation proc…
Sponsor: LUMA Vision Ltd. • Aim: Disease control
Last updated May 26, 2026 04:33 UTC
-
New heart imaging tool tracked in Real-World procedures
Knowledge-focused Not yet recruitingThis study will collect information from 50 adults having standard heart procedures for atrial fibrillation or left atrial appendage closure using the VERAFEYE imaging system. The goal is to see how well the system helps doctors create 3D heart models and complete the procedures …
Sponsor: LUMA Vision Ltd. • Aim: Knowledge-focused
Last updated May 26, 2026 04:39 UTC